SCHEMBL4020001

SCHEMBL4020001

NC(=O)c1ccc(Oc2c(F)cc(C(N)C3Cc4ccccc4C3)cc2F)cc1O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 6/20 0.33
PARP15 Q460N3 3/20 0.33
PARP14 Q460N5 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
ALDH1A1 P00352 3/20 0.31
HPGD P15428 3/20 0.31
KDM4E B2RXH2 2/20 0.31
TSHR P16473 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MAPT P10636 1/20 0.31
MAOB P27338 4/20 0.31
ALOX15 P16050 2/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAOA P21397 2/20 0.31
SCN3A Q9NY46 1/20 0.31
CYP3A4 P08684 2/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024265 0.88 PNLIP (0.38) PARP10PARP15PARP14SCN3ALMNA
SCHEMBL4020004 0.78 FYN (0.42) PARP10PARP15PARP14ALDH1A1KDM4E
SCHEMBL4024269 0.68 LMNA (0.42) MAOBMAOALMNA
SCHEMBL4018676 0.68 PARP10 (0.41) PARP10PARP15ALDH1A1KDM4EMAPT
SCHEMBL4018141 0.67 PARP10 (0.44) PARP10PARP15ALDH1A1KDM4ETSHR
SCHEMBL4016203 0.66 PARP10 (0.39) PARP10PARP15MAOBMAOASCN3A
SCHEMBL4014221 0.65 MEN1 (0.36) PARP10PARP15PARP14HPGDMAPT
SCHEMBL12316316 0.63 PARP10 (0.58) PARP10ALDH1A1HPGDKDM4ETSHR
SCHEMBL4018667 0.63 FPR2 (0.39) PARP10PARP15MAOBMAOA
SCHEMBL2707659 0.62 CTNNB1 (0.59) ALDH1A1HPGDKDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618996-B2 Diaryl ether derivatives and uses thereof PFIZER INC. (US) 2009-11-17 US claimed
EP-2064199-A1 DIARYL ETHER DERIVATIVES AND USES THEREOF Pfizer Products Inc. (US) 2009-06-03 EP claimed
WO-2008032156-A1 DIARYL ETHER DERIVATIVES AND USES THEREOF PFIZER PRODUCTS INC. (US) 2008-03-20 WO claimed
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof PFIZER INC 2008-03-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof OPRD1, OPRK1, OPRL1 PARP10 2285/4885PARP15 3250/4885PARP14 3339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.